Compensatory hyperinsulinemia in insulin-resistant states further activates MAPK pathways, amplifying ET-1 release and upregulating adhesion molecules (e.g., VCAM-1, E-selectin), promoting monocyte adhesion and atherosclerosis [114,115]. This evidence concerns the gene INS and atherosclerosis.